Beat A Volatile FTSE 100 With GlaxoSmithKline plc, Smith & Nephew plc, WPP PLC And Glencore PLC

These 4 stocks could outperform the FTSE 100: GlaxoSmithKline plc (LON: GSK), Smith & Nephew plc (LON: SN), WPP PLC (LON: WPP) and Glencore PLC (LON: GLEN)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

While the FTSE 100 gained a boost from the Conservative election victory, its medium-term outlook may be somewhat uncertain. That’s because, while the UK economy is performing well, the EU referendum could take place next year and, between now and then, the political and investment outlook could change immensely.

Defensive Stocks

For example, the debate surrounding the yes/no question has the potential to cause serious upheaval in the Conservative party. That’s because it remains split on the European question (as it has done for many years), with there being a very real prospect of unrest among backbenchers should the concessions negotiated by David Cameron prove to be insufficient. And, with the prospect of the UK ending up outside of the EU unlikely to improve investor sentiment, defensive stocks such as GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) could be a great place to invest.

Clearly, GlaxoSmithKline’s future growth prospects have a relatively low correlation with the political events and economic outlook for the UK economy. So, there is a good chance that it will outperform the wider index moving forward, as investors seek out defensive stocks. Moreover, GlaxoSmithKline has a bright future, with an improving pipeline and major cost reductions having the potential to return the company to bottom line growth next year after a handful of challenging years.

Another excellent defensive play is Smith & Nephew (LSE: SN). Unlike GlaxoSmithKline, it has an excellent track record of earnings growth, with its bottom line having risen in each of the last five years and averaging growth of 5% per annum during the period. And, looking ahead, it offers relative stability due to consistent demand for its wound care, endoscopy and orthopaedic products, with its bottom line due to rise by as much as 13% next year.

International Exposure

Another company that may see investor sentiment improve over the medium term is WPP (LSE: WPP). While the UK is a key market for the company, it is very much an international play and is often viewed as a barometer of the global economy. And, with the US economy going from strength to strength and China also initiating a series of interest rate cuts in an attempt to stimulate the economy, WPP could see its profit rise at a brisk pace over the next couple of years. And, with it trading on a price to earnings (P/E) ratio of 16.4, it seems to offer good value for money, too.

Also having little reliance upon the UK economy is global mining play, Glencore (LSE: GLEN). Its share price is much more closely linked to the price and outlook for commodities rather than whether the UK remains in the EU or not. And, with it having a strong management team and a dividend yield of 4%, investor sentiment in the company could improve moving forward. That’s especially the case since Glencore currently pays out just 52% of profit as a dividend, which indicates that there is considerable scope for improved income levels moving forward.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

I reckon this S&P 500 stock could be among the best shares for me to buy today

This S&P 500 monopoly stock's trading at a 30% discount to its historical valuation just as growth could be about…

Read more »

Investing Articles

A ridiculously cheap FTSE 250 stock to buy today?

The FTSE 250's rising by double-digits, but this stock's seemingly falling behind despite higher cash flows and dividends. At a…

Read more »

Investing Articles

The FTSE 100’s trading near a 52-week high! I’m still looking to buy

The FTSE 100's slowly making its way towards record highs, but there are still dirt cheap buying opportunities to discover…

Read more »

Smiling senior white man talking through telephone while using laptop at desk.
Investing Articles

1 surging stock I think could gatecrash the FTSE 100 in 2025!

Royston Wild reckons this FTSE 250 share is heading all the way to the Footsie. Here he explains why it's…

Read more »

artificial intelligence investing algorithms
Investing Articles

Should I buy skyrocketing Palantir stock for my ISA in 2025?

This red-hot artificial intelligence share has even outperformed Nvidia so far this year. Is it finally time I added it…

Read more »

Affectionate Asian senior mother and daughter using smartphone together at home, smiling joyfully
Investing Articles

2 of my favourite UK growth shares this December!

These FTSE 250 growth shares offer excellent value right now. Here's why I'll buy them for my portfolio if the…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

10% dividend growth! 2 FTSE 100 stocks tipped to supercharge cash payouts

These FTSE 100 stocks have strong records of dividend growth. And they're expected to keep on delivering, as Royston Wild…

Read more »

Investing Articles

Down 17% in a month and yielding 7.39%! Is this FTSE 100 share a screaming buy for me?

When Harvey Jones bought Taylor Wimpey last year he thought this FTSE 100 share was a brilliant long-term buy-and-hold. Has…

Read more »